Advancing Pulmonary Delivery Platforms for Improved Treatment Options

Aptar Pharma's presentation entitled " A broad range of advanced delivery platforms " explores the current extensive portfolio of high-quality OIDP (Orally Inhaled Drug Products) delivery devices. The presentation also highlights Aptar Pharma's comprehensive services which support respiratory drug development, including device selection, formulation development, analytical methods, and regulatory support.

This discussion aims to showcase Aptar Pharma's latest advancements in inhalation technology, emphasizing their commitment to improving patient care through innovative drug delivery systems. Platforms available through Aptar now include the Orbital high payload DPI, Cambridge Health Innovations’ high efficiency Quattrii DPI and Pulmotree’s high end Vibrating Mesh Non-Propellant Liquid Inhaler Kolibri™.